nodes	percent_of_prediction	percent_of_DWPC	metapath
Apomorphine—ADRA1D—polycystic ovary syndrome	0.428	0.54	CbGaD
Apomorphine—ADRA1B—polycystic ovary syndrome	0.365	0.461	CbGaD
Apomorphine—CALY—pituitary gland—polycystic ovary syndrome	0.00157	0.0978	CbGeAlD
Apomorphine—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.00156	0.097	CcSEcCtD
Apomorphine—Contusion—Metformin—polycystic ovary syndrome	0.00145	0.09	CcSEcCtD
Apomorphine—CALY—endocrine gland—polycystic ovary syndrome	0.00122	0.0758	CbGeAlD
Apomorphine—HTR2A—urine—polycystic ovary syndrome	0.0011	0.0689	CbGeAlD
Apomorphine—Pain in extremity—Metformin—polycystic ovary syndrome	0.000918	0.057	CcSEcCtD
Apomorphine—Dehydration—Metformin—polycystic ovary syndrome	0.000854	0.053	CcSEcCtD
Apomorphine—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.000821	0.051	CcSEcCtD
Apomorphine—Angina pectoris—Metformin—polycystic ovary syndrome	0.000773	0.048	CcSEcCtD
Apomorphine—Sweating increased—Metformin—polycystic ovary syndrome	0.000773	0.048	CcSEcCtD
Apomorphine—Drowsiness—Metformin—polycystic ovary syndrome	0.000707	0.0439	CcSEcCtD
Apomorphine—DRD5—female gonad—polycystic ovary syndrome	0.000662	0.0412	CbGeAlD
Apomorphine—DRD5—endocrine gland—polycystic ovary syndrome	0.000615	0.0384	CbGeAlD
Apomorphine—Flushing—Metformin—polycystic ovary syndrome	0.000589	0.0366	CcSEcCtD
Apomorphine—HTR2B—adrenal cortex—polycystic ovary syndrome	0.000548	0.0342	CbGeAlD
Apomorphine—Syncope—Metformin—polycystic ovary syndrome	0.000496	0.0308	CcSEcCtD
Apomorphine—ADRA1D—endocrine gland—polycystic ovary syndrome	0.000493	0.0308	CbGeAlD
Apomorphine—HTR2B—endometrium—polycystic ovary syndrome	0.000489	0.0305	CbGeAlD
Apomorphine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000486	0.0302	CcSEcCtD
Apomorphine—Chest pain—Metformin—polycystic ovary syndrome	0.000471	0.0292	CcSEcCtD
Apomorphine—Oedema—Metformin—polycystic ovary syndrome	0.000451	0.028	CcSEcCtD
Apomorphine—HTR2B—uterus—polycystic ovary syndrome	0.000451	0.0281	CbGeAlD
Apomorphine—Shock—Metformin—polycystic ovary syndrome	0.000444	0.0276	CcSEcCtD
Apomorphine—HTR2B—adipose tissue—polycystic ovary syndrome	0.000441	0.0275	CbGeAlD
Apomorphine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000436	0.0271	CcSEcCtD
Apomorphine—ADRA2C—adrenal cortex—polycystic ovary syndrome	0.000431	0.0269	CbGeAlD
Apomorphine—Hypotension—Metformin—polycystic ovary syndrome	0.000422	0.0262	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000411	0.0255	CcSEcCtD
Apomorphine—Dyspnoea—Metformin—polycystic ovary syndrome	0.000402	0.025	CcSEcCtD
Apomorphine—Somnolence—Metformin—polycystic ovary syndrome	0.000401	0.0249	CcSEcCtD
Apomorphine—HTR2B—adrenal gland—polycystic ovary syndrome	0.000396	0.0247	CbGeAlD
Apomorphine—Fatigue—Metformin—polycystic ovary syndrome	0.000389	0.0242	CcSEcCtD
Apomorphine—Constipation—Metformin—polycystic ovary syndrome	0.000386	0.024	CcSEcCtD
Apomorphine—ADRA2C—endometrium—polycystic ovary syndrome	0.000385	0.024	CbGeAlD
Apomorphine—HTR1B—endocrine gland—polycystic ovary syndrome	0.000381	0.0237	CbGeAlD
Apomorphine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000372	0.0231	CcSEcCtD
Apomorphine—HTR2B—vagina—polycystic ovary syndrome	0.000367	0.0229	CbGeAlD
Apomorphine—DRD2—pituitary gland—polycystic ovary syndrome	0.000359	0.0223	CbGeAlD
Apomorphine—HTR2A—embryo—polycystic ovary syndrome	0.000357	0.0223	CbGeAlD
Apomorphine—ADRA2C—uterus—polycystic ovary syndrome	0.000355	0.0221	CbGeAlD
Apomorphine—HTR1A—adrenal gland—polycystic ovary syndrome	0.000355	0.0221	CbGeAlD
Apomorphine—ADRA2C—pituitary gland—polycystic ovary syndrome	0.000349	0.0217	CbGeAlD
Apomorphine—ADRA2C—adipose tissue—polycystic ovary syndrome	0.000347	0.0216	CbGeAlD
Apomorphine—Asthenia—Metformin—polycystic ovary syndrome	0.000324	0.0201	CcSEcCtD
Apomorphine—Pruritus—Metformin—polycystic ovary syndrome	0.000319	0.0198	CcSEcCtD
Apomorphine—ADRA2C—adrenal gland—polycystic ovary syndrome	0.000311	0.0194	CbGeAlD
Apomorphine—Diarrhoea—Metformin—polycystic ovary syndrome	0.000309	0.0192	CcSEcCtD
Apomorphine—HTR1A—endocrine gland—polycystic ovary syndrome	0.000307	0.0192	CbGeAlD
Apomorphine—ADRA2A—endometrium—polycystic ovary syndrome	0.000307	0.0192	CbGeAlD
Apomorphine—Dizziness—Metformin—polycystic ovary syndrome	0.000298	0.0185	CcSEcCtD
Apomorphine—ADRA2C—female gonad—polycystic ovary syndrome	0.00029	0.0181	CbGeAlD
Apomorphine—ADRA2C—vagina—polycystic ovary syndrome	0.000289	0.018	CbGeAlD
Apomorphine—Vomiting—Metformin—polycystic ovary syndrome	0.000287	0.0178	CcSEcCtD
Apomorphine—ADRA2A—uterus—polycystic ovary syndrome	0.000283	0.0177	CbGeAlD
Apomorphine—Headache—Metformin—polycystic ovary syndrome	0.000283	0.0176	CcSEcCtD
Apomorphine—ADRA2A—pituitary gland—polycystic ovary syndrome	0.000278	0.0173	CbGeAlD
Apomorphine—DRD2—endocrine gland—polycystic ovary syndrome	0.000278	0.0173	CbGeAlD
Apomorphine—ADRA2A—adipose tissue—polycystic ovary syndrome	0.000277	0.0173	CbGeAlD
Apomorphine—Nausea—Metformin—polycystic ovary syndrome	0.000268	0.0166	CcSEcCtD
Apomorphine—ADRA2A—adrenal gland—polycystic ovary syndrome	0.000248	0.0155	CbGeAlD
Apomorphine—HTR2A—pituitary gland—polycystic ovary syndrome	0.000236	0.0147	CbGeAlD
Apomorphine—ADRA2A—female gonad—polycystic ovary syndrome	0.000232	0.0144	CbGeAlD
Apomorphine—ADRA2A—vagina—polycystic ovary syndrome	0.00023	0.0144	CbGeAlD
Apomorphine—ADRA2A—endocrine gland—polycystic ovary syndrome	0.000215	0.0134	CbGeAlD
Apomorphine—HTR2A—adrenal gland—polycystic ovary syndrome	0.000211	0.0132	CbGeAlD
Apomorphine—HTR2A—vagina—polycystic ovary syndrome	0.000196	0.0122	CbGeAlD
Apomorphine—HTR2A—endocrine gland—polycystic ovary syndrome	0.000183	0.0114	CbGeAlD
Apomorphine—DRD3—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.81e-06	3.9e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.81e-06	3.9e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—NGFR—polycystic ovary syndrome	6.81e-06	3.9e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—ATF1—polycystic ovary syndrome	6.8e-06	3.9e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—AKT2—polycystic ovary syndrome	6.79e-06	3.89e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—NRG1—polycystic ovary syndrome	6.77e-06	3.88e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—POMC—polycystic ovary syndrome	6.76e-06	3.88e-05	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	6.76e-06	3.87e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—PRL—polycystic ovary syndrome	6.74e-06	3.87e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.72e-06	3.85e-05	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.71e-06	3.84e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—IRS2—polycystic ovary syndrome	6.69e-06	3.83e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—ATF1—polycystic ovary syndrome	6.69e-06	3.83e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—NRG1—polycystic ovary syndrome	6.68e-06	3.83e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.68e-06	3.83e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—NRG1—polycystic ovary syndrome	6.68e-06	3.83e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	6.63e-06	3.8e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—AKT2—polycystic ovary syndrome	6.6e-06	3.79e-05	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	6.6e-06	3.78e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—CYP19A1—polycystic ovary syndrome	6.56e-06	3.76e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—IRS2—polycystic ovary syndrome	6.55e-06	3.76e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—LEP—polycystic ovary syndrome	6.55e-06	3.75e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	6.52e-06	3.74e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—CYP1A1—polycystic ovary syndrome	6.51e-06	3.73e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.5e-06	3.73e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	6.5e-06	3.73e-05	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	6.49e-06	3.72e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—GNAS—polycystic ovary syndrome	6.45e-06	3.7e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—IRS2—polycystic ovary syndrome	6.45e-06	3.7e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—LEP—polycystic ovary syndrome	6.41e-06	3.67e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.4e-06	3.67e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—GHRL—polycystic ovary syndrome	6.38e-06	3.66e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PLAT—polycystic ovary syndrome	6.38e-06	3.66e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—LEP—polycystic ovary syndrome	6.31e-06	3.62e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—NGFR—polycystic ovary syndrome	6.27e-06	3.6e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—POMC—polycystic ovary syndrome	6.23e-06	3.57e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—GNAS—polycystic ovary syndrome	6.23e-06	3.57e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PRL—polycystic ovary syndrome	6.22e-06	3.56e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—GNAS—polycystic ovary syndrome	6.2e-06	3.55e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—NGFR—polycystic ovary syndrome	6.17e-06	3.54e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—IRS2—polycystic ovary syndrome	6.15e-06	3.53e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.15e-06	3.52e-05	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	6.15e-06	3.52e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—POMC—polycystic ovary syndrome	6.13e-06	3.52e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PRL—polycystic ovary syndrome	6.12e-06	3.51e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Hemostasis—VEGFA—polycystic ovary syndrome	6.11e-06	3.5e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—ATF1—polycystic ovary syndrome	6.09e-06	3.49e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—MTHFR—polycystic ovary syndrome	6.07e-06	3.48e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—NRG1—polycystic ovary syndrome	6.03e-06	3.46e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—GNAS—polycystic ovary syndrome	6.03e-06	3.46e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—LEP—polycystic ovary syndrome	6.02e-06	3.45e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—AKT2—polycystic ovary syndrome	5.99e-06	3.44e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	5.94e-06	3.4e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.93e-06	3.4e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—GNAS—polycystic ovary syndrome	5.93e-06	3.4e-05	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	5.91e-06	3.39e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.9e-06	3.38e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—ADRB2—polycystic ovary syndrome	5.9e-06	3.38e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	5.9e-06	3.38e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—GNAS—polycystic ovary syndrome	5.86e-06	3.36e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—IRS1—polycystic ovary syndrome	5.84e-06	3.35e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—NRG1—polycystic ovary syndrome	5.83e-06	3.34e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	5.8e-06	3.33e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IRS2—polycystic ovary syndrome	5.8e-06	3.33e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—NRG1—polycystic ovary syndrome	5.8e-06	3.32e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.74e-06	3.29e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IRS2—polycystic ovary syndrome	5.73e-06	3.28e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IRS2—polycystic ovary syndrome	5.73e-06	3.28e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—IRS1—polycystic ovary syndrome	5.72e-06	3.28e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—LEP—polycystic ovary syndrome	5.68e-06	3.26e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.65e-06	3.24e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—NRG1—polycystic ovary syndrome	5.64e-06	3.23e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—IRS1—polycystic ovary syndrome	5.63e-06	3.23e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—POMC—polycystic ovary syndrome	5.62e-06	3.22e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—NGFR—polycystic ovary syndrome	5.62e-06	3.22e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—LEP—polycystic ovary syndrome	5.6e-06	3.21e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—LEP—polycystic ovary syndrome	5.6e-06	3.21e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—INS—polycystic ovary syndrome	5.59e-06	3.21e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—POMC—polycystic ovary syndrome	5.58e-06	3.2e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—NCOR1—polycystic ovary syndrome	5.58e-06	3.2e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PRL—polycystic ovary syndrome	5.57e-06	3.19e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—NRG1—polycystic ovary syndrome	5.55e-06	3.18e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—POMC—polycystic ovary syndrome	5.51e-06	3.16e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—INS—polycystic ovary syndrome	5.48e-06	3.14e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—GNAS—polycystic ovary syndrome	5.47e-06	3.14e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—POMC—polycystic ovary syndrome	5.42e-06	3.11e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—IGF1—polycystic ovary syndrome	5.41e-06	3.1e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—AKT2—polycystic ovary syndrome	5.41e-06	3.1e-05	CbGpPWpGaD
Apomorphine—DRD5—Signaling by GPCR—IL6—polycystic ovary syndrome	5.4e-06	3.1e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—INS—polycystic ovary syndrome	5.39e-06	3.09e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—GNAS—polycystic ovary syndrome	5.38e-06	3.09e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—IRS1—polycystic ovary syndrome	5.37e-06	3.08e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	5.36e-06	3.08e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—IGF1—polycystic ovary syndrome	5.3e-06	3.04e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—AKT2—polycystic ovary syndrome	5.29e-06	3.03e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—CYP1A1—polycystic ovary syndrome	5.29e-06	3.03e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	5.28e-06	3.03e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—IGF1—polycystic ovary syndrome	5.21e-06	2.99e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.21e-06	2.99e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—AKT2—polycystic ovary syndrome	5.21e-06	2.99e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—POMC—polycystic ovary syndrome	5.17e-06	2.97e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IRS2—polycystic ovary syndrome	5.17e-06	2.96e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—INS—polycystic ovary syndrome	5.14e-06	2.95e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.14e-06	2.94e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.13e-06	2.94e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	5.11e-06	2.93e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	5.07e-06	2.9e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—LEP—polycystic ovary syndrome	5.06e-06	2.9e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—NRG1—polycystic ovary syndrome	5.03e-06	2.89e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.03e-06	2.88e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IRS1—polycystic ovary syndrome	5e-06	2.87e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IRS1—polycystic ovary syndrome	5e-06	2.87e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	4.99e-06	2.86e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—IGF1—polycystic ovary syndrome	4.98e-06	2.85e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—AKT2—polycystic ovary syndrome	4.97e-06	2.85e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IRS2—polycystic ovary syndrome	4.96e-06	2.85e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.95e-06	2.84e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—MTHFR—polycystic ovary syndrome	4.93e-06	2.83e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—PPARG—polycystic ovary syndrome	4.92e-06	2.82e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	4.9e-06	2.81e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—LEP—polycystic ovary syndrome	4.88e-06	2.8e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—POMC—polycystic ovary syndrome	4.88e-06	2.8e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—LEP—polycystic ovary syndrome	4.86e-06	2.78e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—POMC—polycystic ovary syndrome	4.85e-06	2.78e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—INS—polycystic ovary syndrome	4.85e-06	2.78e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IRS2—polycystic ovary syndrome	4.83e-06	2.77e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—INS—polycystic ovary syndrome	4.83e-06	2.77e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—POMC—polycystic ovary syndrome	4.81e-06	2.76e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—POMC—polycystic ovary syndrome	4.81e-06	2.76e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—INS—polycystic ovary syndrome	4.79e-06	2.74e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—INS—polycystic ovary syndrome	4.79e-06	2.74e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IRS2—polycystic ovary syndrome	4.75e-06	2.72e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—LEP—polycystic ovary syndrome	4.73e-06	2.71e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.73e-06	2.71e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	4.69e-06	2.69e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	4.69e-06	2.69e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.66e-06	2.67e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—LEP—polycystic ovary syndrome	4.65e-06	2.67e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IGF1—polycystic ovary syndrome	4.63e-06	2.65e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IGF1—polycystic ovary syndrome	4.63e-06	2.65e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—AKT2—polycystic ovary syndrome	4.63e-06	2.65e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—AKT2—polycystic ovary syndrome	4.63e-06	2.65e-05	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.61e-06	2.64e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	4.58e-06	2.62e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IRS1—polycystic ovary syndrome	4.51e-06	2.59e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.46e-06	2.55e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.4e-06	2.52e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.4e-06	2.52e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	4.38e-06	2.51e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	4.36e-06	2.5e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—POMC—polycystic ovary syndrome	4.35e-06	2.49e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IRS1—polycystic ovary syndrome	4.33e-06	2.48e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—INS—polycystic ovary syndrome	4.32e-06	2.48e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	4.31e-06	2.47e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	4.29e-06	2.46e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	4.22e-06	2.42e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IRS1—polycystic ovary syndrome	4.22e-06	2.42e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	4.19e-06	2.4e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IGF1—polycystic ovary syndrome	4.18e-06	2.4e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—AKT2—polycystic ovary syndrome	4.18e-06	2.39e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—POMC—polycystic ovary syndrome	4.17e-06	2.39e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	4.17e-06	2.39e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—INS—polycystic ovary syndrome	4.15e-06	2.38e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	4.15e-06	2.38e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling by GPCR—IL6—polycystic ovary syndrome	4.14e-06	2.37e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—POMC—polycystic ovary syndrome	4.06e-06	2.33e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling by GPCR—IL6—polycystic ovary syndrome	4.05e-06	2.32e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—INS—polycystic ovary syndrome	4.04e-06	2.31e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	4.03e-06	2.31e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	4.03e-06	2.31e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IGF1—polycystic ovary syndrome	4.01e-06	2.3e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—AKT2—polycystic ovary syndrome	4.01e-06	2.3e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	4e-06	2.29e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	3.99e-06	2.29e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—IL6—polycystic ovary syndrome	3.99e-06	2.29e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	3.97e-06	2.28e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.97e-06	2.28e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	3.94e-06	2.26e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	3.92e-06	2.25e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—INS—polycystic ovary syndrome	3.92e-06	2.25e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IGF1—polycystic ovary syndrome	3.9e-06	2.24e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—AKT2—polycystic ovary syndrome	3.9e-06	2.24e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	3.84e-06	2.2e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	3.84e-06	2.2e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	3.84e-06	2.2e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.83e-06	2.2e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	3.82e-06	2.19e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.81e-06	2.19e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—IL6—polycystic ovary syndrome	3.81e-06	2.18e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	3.76e-06	2.16e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.71e-06	2.13e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	3.68e-06	2.11e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	3.66e-06	2.1e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.65e-06	2.09e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	3.62e-06	2.08e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	3.6e-06	2.07e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	3.59e-06	2.06e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	3.54e-06	2.03e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—IL6—polycystic ovary syndrome	3.54e-06	2.03e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—IL6—polycystic ovary syndrome	3.54e-06	2.03e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	3.54e-06	2.03e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.53e-06	2.03e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	3.49e-06	2e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	3.48e-06	2e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.46e-06	1.98e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	3.42e-06	1.96e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.4e-06	1.95e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.36e-06	1.93e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.31e-06	1.9e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	3.3e-06	1.89e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	3.28e-06	1.88e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.25e-06	1.86e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—IL6—polycystic ovary syndrome	3.2e-06	1.83e-05	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—IL6—polycystic ovary syndrome	3.19e-06	1.83e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	3.17e-06	1.82e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	3.17e-06	1.82e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	3.09e-06	1.77e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—IL6—polycystic ovary syndrome	3.07e-06	1.76e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.06e-06	1.76e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.02e-06	1.73e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.02e-06	1.73e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.01e-06	1.73e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—IL6—polycystic ovary syndrome	2.99e-06	1.71e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	2.94e-06	1.68e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.73e-06	1.57e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	2.71e-06	1.55e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.67e-06	1.53e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.64e-06	1.51e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.62e-06	1.5e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.55e-06	1.46e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.51e-06	1.44e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—IL6—polycystic ovary syndrome	2.44e-06	1.4e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.43e-06	1.39e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—IL6—polycystic ovary syndrome	2.39e-06	1.37e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—IL6—polycystic ovary syndrome	2.35e-06	1.35e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.31e-06	1.33e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.28e-06	1.31e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—IL6—polycystic ovary syndrome	2.25e-06	1.29e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IL6—polycystic ovary syndrome	2.12e-06	1.22e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IL6—polycystic ovary syndrome	2.09e-06	1.2e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IL6—polycystic ovary syndrome	2.09e-06	1.2e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.07e-06	1.19e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IL6—polycystic ovary syndrome	1.89e-06	1.08e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	1.82e-06	1.04e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IL6—polycystic ovary syndrome	1.81e-06	1.04e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IL6—polycystic ovary syndrome	1.76e-06	1.01e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	1.74e-06	9.95e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	1.6e-06	9.17e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	1.57e-06	9.03e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	1.43e-06	8.21e-06	CbGpPWpGaD
